The Grant for Oncology Innovation (GOI) is an initiative funded by EMD Serono, a subsidiary of Merck KGaA, Darmstadt, Germany, to identify and support innovative projects to advance research on personalised treatment for solid tumors.
The grant programme was launched to coincide with the European Cancer Congress (ECCO-ESMO-ESTRO) in Amsterdam, September-October, 2013.
Applications for the 2014 GOI award are closed. The awardees will be announced during the ESMO Congress, 26-30 September, Madrid, Spain.
Should you wish to apply for the 2015 grant, applications will re-open from 1 October 2014.